COR
Cencora, Inc. · Healthcare · Medical - Distribution
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 466.89K | $143.79M | n/a | −1 |
| Q2 2026 | 161 | 0 | 138.36M | $39.16B | +5 | −6 |
| Q1 2026 | 165 | -4 | 143.75M | $45.15B | +4 | −9 |
| Q4 2025 | 168 | -1 | 154.98M | $52.35B | +1 | −1 |
| Q3 2025 | 24 | +1 | 95.47M | $29.83B | +1 | −1 |
| Q2 2025 | 21 | 0 | 79.61M | $23.87B | n/a | n/a |
| Q1 2025 | 18 | +1 | 37.02M | $10.29B | +2 | −1 |
| Q4 2024 | 17 | 0 | 34.14M | $7.67B | n/a | n/a |
| Q3 2024 | 16 | 0 | 25.36M | $5.70B | n/a | n/a |
| Q2 2024 | 16 | n/a | 24.85M | $5.60B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 229.36K | -80.5% | $68.87M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 165.53K | +2.1% | $52.61M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | TD Waterhouse Canada Inc. | 71.99K | +10.1% | $22.32M | 0.1% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Robeco Institutional Asset… | $25.90M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,407 holders, 152.27M shares, $41.91B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 986 sh · $298,935
Director · 1.28K sh · $411,264
Officer · 985 sh · $321,080
Officer · 11.30K sh · $3.66M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology